Malignant glioma

Related records

Broader conditions (17)

• Cancer
• Cancer or benign tumor
• Central nervous system cancer
• Central nervous system disorder
• Central nervous system neoplasm
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Glioma
• High grade malignant neoplasm
• Human disease
• Neoplasm
• Neoplastic disease or syndrome
• Nervous system cancer
• Nervous system disorder
• Nervous system neoplasm
• Neuroepithelial neoplasm

Narrower conditions (99)

• Adult anaplastic ependymoma
• Adult brain ependymoma
• Adult brainstem astrocytoma
• Adult brainstem glioma
• Adult brainstem gliosarcoma
• Adult brainstem mixed glioma
• Adult glioblastoma
• Adult malignant schwannoma
• Adult oligodendroglioma
• Adult spinal cord ependymoma
• Adult spinal cord glioblastoma
• Anaplastic astrocytoma
• Anaplastic ependymoma
• Anaplastic oligoastrocytoma
• Anaplastic oligodendroglioma
• Astrocytoma, IDH-mutant, grade 2
• Astrocytoma, IDH-mutant, grade 3
• Astrocytoma, IDH-mutant, grade 4
• Brain glioblastoma
• Brain glioma

Trials (392)

• 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
• 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
• 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
• 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
• 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas
• 18F-Fluciclovine PET-MRI in High-grade Glioma
• 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas
• 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor
• 68Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma
• 9-ING-41 in Patients With Advanced Cancers
• A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma
• A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
• A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors
• A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas
• A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
• A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
• A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
• A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
• A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma
• A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

Approved drugs (3)

• Aminolevulinic acid hydrochloride
• Carmustine
• Temozolomide

Drugs in development (240)

• 6-O-benzylguanine Phase 2
• Abacavir Phase 1
• Abemaciclib Early phase 1
• AC-480 Phase 1
• Acetaminophen Phase 2
• ACT-001 Phase 2
• Afatinib Phase 2
• Aflibercept Phase 1
• Aglatimagene besadenovec Phase 1
• Alanine Early phase 1
• Alanosine Phase 1
• Aldesleukin Phase 1
• Alisertib Phase 1
• Alisertib sodium Phase 1
• AMG-404 Phase 1
• Amino acids Phase 2
• Aminolevulinic acid Phase 1
• ANG1005 Phase 1
• Antineoplaston A10 Phase 2
• Armodafinil Phase 2

Other linked drugs (5)

• Alovudine F-18
• Busulfan
• Lacosamide
• MAB-425
• Rivaroxaban